We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA on Friday granted Gilead’s remdesivir an Emergency Use Authorization (EUA) as a COVID-19 treatment, based on positive results from two clinical trials. Read More
Immunomedic’s Trodelvy (sacituzumab govitecan-hziy) earned accelerated approval for treatment of adults with triple-negative breast cancer that has metastasized. Read More